Sarepta Therapeutics (SRPT) Form 8-K Summary

Date of Report: November 03, 2025

This 8-K primarily serves to report the release of quarterly financial results.

• Item Reported: Item 2.02 (Results of Operations and Financial Condition).
• Event: Sarepta issued a press release announcing financial results for the quarter ended September 30, 2025.
• Key Takeaway: All specific financial performance data, metrics, and guidance are contained within the furnished Exhibit 99.1 (the press release). Investors must review Exhibit 99.1 for details on Q3 2025 performance.